Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
Archive print banner
National Healthcare Quality Report, 2007

Effectiveness of Care: HIV and AIDS

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.


AIDS Prevention
New AIDS cases per 100,000 population age 13 and over
Management of HIV/AIDS
HIV-infection deaths per 100,000 population
HIV patients with CD4 < 200 who received PCP prophylaxis
HIV patients with CD4 < 50 who received MAC prophylaxis
Women ages 15-44 who completed a pregnancy in the last 12 months and had an HIV test as part of prenatal care
Population ages 15-44 who ever had an HIV test outside of blood donation
Population ages 15-44 with any HIV risk behaviors in the last 12 months who had an HIV test outside of blood donation in the last 12 months

AIDS Prevention

Measure Title

New AIDS cases per 100,000 population age 13 and over.

Measure Source

Healthy People 2010.

Tables

1.65 New AIDS cases per 100,000 population age 13 and over, United States, 1998 and 2005.

Data Source

Centers for Disease Control and Prevention (CDC), National HIV/AIDS Surveillance System.

Denominator

U.S. population: adolescents and adults age 13 and over.

Numerator

Number of reported new AIDS cases among adolescents and adults age 13 and over.

Comments

The AIDS case definition used by the HIV/AIDS Reporting System for an AIDS case is provided by the CDC. Data are adjusted for reporting delay. Data exclude cases from U.S. dependencies, possessions, and independent nations in free association with the United States.

This measure is referred to as measure 13-1 in Healthy People 2010 documentation.

Top of Page

Management of HIV/AIDS

Measure Title

HIV-infection deaths per 100,000 population.

Measure Source

Healthy People 2010.

National Tables

1.66a HIV-infection deaths per 100,000 population, United States, 1999 and 2004.

National Data Source

Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Vital Statistics System-Mortality (NVSS-M).

National Denominator

U.S. population.

National Numerator

Number of deaths due to HIV infection (ICD-10-CM codes B20-B24).

State Tables

1.66b HIV-infection deaths per 100,000 population, by State, 1999 and 2004.

State Data Source

CDC, NCHS, NVSS-M.

State Denominator

Population by State.

State Numerator

Same as national.

Comments

Rates are age adjusted to the 2000 standard population. Age-adjusted rates are weighted sums of age-specific rates. Resident death data are based on information from death certificates filed in the 50 States and the District of Columbia.

This measure is referred to as measure 13-14 in Healthy People 2010 documentation.

Top of Page

Management of HIV/AIDS

Measure Title

HIV patients with CD4 < 200 who received PCP prophylaxis.

Measure Source

The HIV Research Network.

Tables

1.67 HIV patients age 18 and over with CD4 cell count less than 200 who received PCP prophylaxis, by race, United States, 2003 and 2004.

Data Source

HIV Research Network, sponsored by multiple Federal agencies: Agency for Healthcare Research and Quality, Substance Abuse and Mental Health Services Administration, Health Resources and Services Administration, and Office of AIDS Research/National Institutes of Health (HIV Research Network), HIV Research Network.

Denominator

Patients diagnosed with HIV with CD4 counts < 200 cells/mm.

Numerator

Subset of denominator who received PCP prophylactic therapy.

Comments

The taxonomy of the PCP organism has been changed; pneumocystis jiroveci refers to the distinct species that infects humans. The abbreviation PCP is still used to designate pneumocystis pneumonia.

For further information see Centers for Disease Control and Prevention: Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR 20 04; 53 (No. RR-15): available from the CDC Web site at http://www.cdc.gov/mmwr/.

Top of Page

Management of HIV/AIDS

Measure Title

HIV patients with CD4 < 50 who received MAC prophylaxis.

Measure Source

The HIV Research Network.

Tables

1.68 HIV patients age 18 and over with CD4 cell count less than 50 who received MAC prophylaxis, by race, United States, 2003 and 2004.

Data Source

HIV Research Network, sponsored by multiple Federal agencies: Agency for Healthcare Research and Quality, Substance Abuse and Mental Health Services Administration, Health Resources and Services Administration, and Office of AIDS Research/National Institutes of Health (HIV Research Network), HIV Research Network

Denominator

Patients diagnosed with HIV with CD4 counts < 50 cells/mm.

Numerator

Subset of denominator who received MAC prophylactic therapy.

Comments

For further information see Centers for Disease Control and Prevention: Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR 20 04; 53 (No. RR-15): available from the CDC Web site at http://www.cdc.gov/mmwr/.

Top of Page

Management of HIV/AIDS

Measure Title

Women ages 15-44 who completed a pregnancy in the last 12 months and had an HIV test as part of prenatal care.

Measure Source

Centers for Disease Control and Prevention (CDC), National Survey of Family Growth (NSFG).

Tables

1.69 Percent of women ages 15-44 who completed a pregnancy in the last 12 months and had an HIV test as part of prenatal care, United States, 2002.

Data Source

CDC, National Center for Health Statistics (NCHS), NSFG.

Denominator

Women ages 15-44 who completed a pregnancy in the last 12 months.

Numerator

Subset of the denominator who had an HIV test as part of prenatal care.

Comments

Percentages are weighted to reflect the national household population of persons 15-44 years of age.

Top of Page

Management of HIV/AIDS

Measure Title

Population ages 15-44 who ever had an HIV test outside of blood donation.

Measure Source

Centers for Disease Control and Prevention (CDC), National Survey of Family Growth (NSFG).

Tables

1.70 Percent of population ages 15-44 who ever had an HIV test outside of blood donation, United States, 2002.

Data Source

CDC, National Center for Health Statistics (NCHS), NSFG.

Denominator

U.S. civilian noninstitutionalized adults ages 15-44.

Numerator

Subset of the denominator who ever had an HIV test outside of blood donation.

Comments

Percentages are weighted to reflect the national household population of women 15-44 years of age.

Top of Page

Management of HIV/AIDS

Measure Title

Population ages 15-44 with any HIV risk behaviors in the last 12 months who had an HIV test outside of blood donation in the last 12 months.

Measure Source

Centers for Disease Control and Prevention (CDC), National Survey of Family Growth (NSFG).

Tables

1.71 Percent of population ages 15-44 with any HIV risk behaviors in the last 12 months who had an HIV test outside of blood donation in the last 12 months, United States, 2002.

Data Source

CDC, National Center for Health Statistics (NCHS), NSFG.

Denominator

Persons age 15-44 who reported risk behaviors for HIV in the past 12 months.

Numerator

Subset of the denominator who reported ever having an HIV test outside of blood donation.

Comments

Percentages are weighted to reflect the national household population of persons 15-44 years of age.

In the self-administered portion of the NSFG interview (Audio Computer-Assisted Self-Interview, or ACASI), all survey respondents were asked about various drug-related and sexual behaviors that increase risk of HIV infection. This table is based on those persons who reported any of the following HIV risk behaviors in the 12 months prior to interview in 2002: crack cocaine or illicit intravenous drug use (IVDU), an IVDU sexual partner, five or more opposite-sex partners, any same-sex partners (if respondent is male), a male partner who has had sex with males (if respondent is female), an HIV-positive sexual partner, exchanging sex for money or drugs, or treatment for sexually transmitted disease (STD). These particular behaviors were used for defining HIV risk status because they correlate most closely with the most common HIV transmission categories identified and monitored by the CDC.

For further information about how HIV risk was defined for this measure, see CDC publication Advance Data From Vital and Health Statistics, numbers 363 and 377, available at http://www.cdc.gov/nchs/.

Top of Page
Return to Contents
Proceed to Next Section

 

The information on this page is archived and provided for reference purposes only.

 

AHRQ Advancing Excellence in Health Care